Search

everythinglearnresearchcommunity

for

Search:↓

Iron deficiency is linked to hair loss in CTE patients.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Individualized homeopathy improved hair health and emotional well-being in a woman with stress-related hair loss.

Plum blossom acupuncture and electroacupuncture improved hair growth and quality of life in a woman with chronic hair loss.

Low serum ferritin is linked to hair loss in women.

Diffuse telogen alopecia is temporary hair loss treated by addressing the root cause and improving scalp health.

A standardized guideline would improve Telogen Effluvium management.

Low iron levels may be linked to hair loss in women with chronic telogen effluvium.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.

Sandalore®, a synthetic scent, improved hair loss and satisfaction in women with telogen effluvium.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

The herbal extract was found to effectively reduce and prevent hair loss without any side effects.

A dietary supplement with Boswellia serrata, Curcuma longa, and Vitis vinifera showed potential improvement in hair health for telogen effluvium patients, but more research is needed.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.